QA: Bolt Biotherapeutics Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001641281_2023_Bolt_Biotherapeutics_Inc.pdf

Logs

Graph

Absolute values for 0001641281, Bolt Biotherapeutics Inc.

  xvar xval
0 AssetsCurrent 172,746,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 6,453,000
3 remainder_Assets 48,608,000
4 LiabilitiesCurrent 23,118,000
5 LiabilitiesNoncurrent 20,262,000
6 remainder_Liabilities 12,921,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 22,927,000
9 ResearchAndDevelopmentExpense 73,123,000
10 remainder_Expenses 0
11 remainder_Revenues 5,729,000
12 remainder_NetIncome 2,223,000
13 remainder_ComprehensiveNetIncome -598,000
  yvar yval
0 Assets 227,807,000
1 Liabilities 56,301,000
2 Expenses 96,050,000
3 Revenues 5,729,000
4 StockholdersEquity 171,506,000
5 NetIncome -88,098,000
6 ComprehensiveNetIncome -88,397,000
7 BaseVar 194,354,000
8 EconomicCapitalRatio 1.45

Edgar->Model Mapping

Feature Distribution

Change over Time